MEI Pharma (NASDAQ: MEIP) has launched a $100 million Litecoin treasury strategy, with backing from Titan Partners Group and crypto firm GSR. Litecoin creator Charlie Lee will join MEI’s board, and the Litecoin Foundation has also invested. The stock price of MEIP surged from $4.2 to $11.45 before plummeting to $6.
Disclaimer: Includes third-party opinions. No financial advice. May include sponsored content.See T&Cs.